WSC 2022

This site is intended for healthcare professionals

From Medscape Neurology

Coverage from the

14th World Stroke Congress (WSC) 2022

October 26 - 29, 2022; Singapore, and Virtual

October 26 - 29, 2022 Singapore, and Virtual

Conference News

WSC 2022 Earlier Anticoagulation Better After Ischemic Stroke in AF?
Medscape Medical News, November 3, 2022

1
WSC 2022 Combo Thrombolytic Approach Fails to Reduce ICH in Stroke
Medscape Medical News, November 2, 2022
WSC 2022 Stroke Thrombectomy Fails Non-inferiority to Combined Therapy
Medscape Medical News, October 31, 2022

WSC 2022 Intensive BP Lowering Harmful in Acute Ischemic Stroke
Medscape Medical News, October 28, 2022

7
WSC 2022 Collateral Flow Flags Stroke Patients for Late Thrombectomy
Medscape Medical News, October 27, 2022

Disclaimer

Credits:
Lead image: Anekoho/Dreamstime

Medscape Neurology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News from WSC 2021

Stroke Thrombectomy Alone Fails Noninferiority to Bridging tPA The SWIFT DIRECT trial failed to show that direct thrombectomy was noninferior to intravenous thrombolysis plus thrombectomy for patients with stroke resulting from large-vessel occlusion.
Medscape Medical News, Nov 09, 2021
Ticagrelor Better Prevents Stroke in Poor Clopidogrel Metabolizers In stroke patients carrying CYP2C19 loss-of-function alleles that impede metabolism of clopidogrel, ticagrelor was more effective than clopidogrel at reducing recurrent stroke in the CHANCE-2 trial.
Medscape Medical News, Oct 29, 2021
No Reduction in WMH Progression With Allopurinol After Stroke Use of allopurinol, a xanthine oxidase inhibitor, did not reduce progression of white matter hyperintensity (WMH) after stroke in a randomized trial.
Medscape Medical News, Nov 15, 2021

Related Coverage

Related Resources

Stroke, Cerebrovascular Disease News & Perspectives